Skip to main content
Clinical Trials/JPRN-UMIN000047529
JPRN-UMIN000047529
Recruiting
N/A

Preliminary study for evaluating novel biomarker in the pathogenesis of breast cancer - Preliminary study for evaluating novel biomarker in the pathogenesis of breast cancer

Kobe City Medical Center General Hospital0 sites60 target enrollmentJune 1, 2022
ConditionsBreast cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Kobe City Medical Center General Hospital
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2022
End Date
March 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • i) In pregnant or with the possibility of pregnancy ii) Selective estrogen\-receptor degrader or selective estrogen\-receptor modulator are administered within 30 days of FES PET iii) Referring doctor decided inappropriate to join this study

Outcomes

Primary Outcomes

Not specified

Similar Trials